| Crystal Structure of a Recombinant IgE Fab Fragment in Complex with Bovine Beta-Lactoglobulin Aller… | |
Heteromer
| 20-178 | 100 | 2×LMT; |
|
| Bovine beta-lactoglobulin complex with myristic acid | | homo-2-mer | 17-178 | 100.0 | 2×MYR; 2×GOL; |
|
| Bovine beta-lactoglobulin variant A at pH 4.0 | | homo-2-mer | 17-178 | 98.77 | 2×NO3; |
|
| Bovine beta-lactoglobulin complex with linoleic acid | | homo-2-mer | 17-178 | 100.0 | 2×EIC; 2×GOL; 2×EOH; |
|
| Bovine beta-lactoglobulin complex with stearic acid | | homo-2-mer | 17-178 | 100.0 | 2×STE; 6×EOH; |
|
| Bovine beta-lactoglobulin (isoform A) in complex with dodecyltrimethylammonium (DTAC) | | homo-2-mer | 17-178 | 98.73 | 2×CAT; |
|
| Engineered beta-lactoglobulin: variant L58F | | homo-2-mer | 17-178 | 98.09 | 2×ACT; |
|
| Bovine beta-lactoglobulin (isoform B) in complex with dodecyltrimethylammonium (DTAC) | | homo-2-mer | 17-178 | 100.0 | 2×CAT; 2×GOL; |
|
| Bovine beta-lactoglobulin complex with tetracaine (BLG-TET) | | homo-2-mer | 17-178 | 100.0 | 2×TE4; |
|
| Bovine beta-lactoglobulin (isoform A) in complex with lauric acid (C12) | | homo-2-mer | 17-178 | 98.73 | 2×DAO; |
|
| 12-BROMODODECANOIC ACID BINDS INSIDE THE CALYX OF BOVINE BETA-LACTOGLOBULIN | | homo-2-mer | 17-178 | 98.77 | 2×BRC; |
|
| STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT … | | homo-2-mer | 17-178 | 98.77 | |
|
| Bovine beta-lactoglobulin (isoform B) in complex with dodecyl sulphate (SDS) | | homo-2-mer | 17-178 | 100.0 | 2×SDS; 2×GOL; |
|
| Bovine beta-lactoglobulin (isoform A) in complex with dodecyl sulphate (SDS) | | homo-2-mer | 17-178 | 98.73 | 2×SDS; |
|
| Energetic and structural effects of the Tanford transition on the ligand recognition of bovine Beta… | | homo-2-mer | 17-178 | 100 | 3×SDS; |
|
| STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT … | | homo-2-mer | 17-178 | 98.77 | |
|
| Recombinant bovine beta-lactoglobulin with uncleaved N-terminal methionine (rBlgB) | | homo-2-mer | 17-178 | 100.0 | 2×GOL; 2×MYR; 2×SIN; |
|
| Recombinant bovine beta-lactoglobulin variant L1A/I2S with endogenous ligand (sBlgB#1) | | homo-2-mer | 17-178 | 98.73 | 2×MYR; |
|
| Bovine beta-lactoglobulin complex with dodecyl sulfate | | homo-2-mer | 18-178 | 100.0 | 2×SDS; 2×GOL; |
|
| Mutant I56F of recombinant bovine beta-lactoglobulin in complex with tetracaine | | homo-2-mer | 18-178 | 98.72 | 3×SO4; 1×TE4; |
|
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W), unliganded form | | homo-2-mer | 18-178 | 97.47 | 2×EDO; |
|
| Engineered beta-lactoglobulin: variant F105L-L39A-M107F in complex with chlorpromazine (LG-LAF-CLP) | | homo-2-mer | 18-178 | 97.48 | 2×Z80; |
|
| Bovine lactoglobulin complex with decanol | | homo-2-mer | 18-178 | 100.0 | 2×DE1; |
|
| Bovine beta-lactoglobulin complex with palmitic acid | | homo-2-mer | 18-178 | 100.0 | 2×PLM; 6×EOH; |
|
| Trigonal form of WT recombinant bovine beta-lactoglobulin | | homo-2-mer | 18-178 | 99.36 | 4×EDO; 2×EOH; |
|
| Bovine beta-lactoglobulin complex with lauric acid | | homo-2-mer | 18-178 | 100.0 | 2×DAO; 2×CL; |
|
| Bovine beta-lactoglobulin complex with oleic acid | | homo-2-mer | 18-178 | 100.0 | 2×OLA; 2×EOH; 2×GOL; |
|
| Mutant L39Y of recombinant beta-lactoglobulin in complex with endogenous ligand | | homo-2-mer | 18-178 | 98.68 | 2×DAO; 2×CL; |
|
| Engineered beta-lactoglobulin: variant F105L-L39A in complex with chlorpromazine (LG-LA-CLP) | | homo-2-mer | 18-178 | 98.1 | 2×Z80; 2×PO4; |
|
| Bovine beta-lactoglobulin complex with pramocaine crystallized from ammonium sulphate (BLG-PRM2) | | homo-2-mer | 18-178 | 100.0 | 2×PX9; |
|
| BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOIC ACID, TRIGONAL LATTICE Z | | homo-2-mer | 18-178 | 100 | 2×REA; |
|
| BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL AND PALMITIC ACID, TRIGONAL LATTICE Z | | homo-2-mer | 18-178 | 100 | 2×PLM; |
|
| BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH RETINOL, TRIGONAL LATTICE Z | | homo-2-mer | 18-178 | 100 | 2×RTL; |
|
| BOVINE BETA-LACTOGLOBULIN COMPLEXED WITH PALMITATE, LATTICE Z | | homo-2-mer | 18-178 | 100 | 2×PLM; |
|
| Mutant F105A of recombinant beta-lactoglobulin in complex with endogenous ligand | | homo-2-mer | 19-178 | 99.36 | 2×DAO; 2×SO4; |
|
| Engineered beta-lactoglobulin: variant I56F | | homo-2-mer | 19-178 | 99.36 | 2×SO4; 4×GOL; |
|
| Mutant F105L of recombinant beta-lactoglobulin | | homo-2-mer | 19-178 | 99.36 | 4×GOL; 2×SO4; |
|
| Engineered beta-lactoglobulin: variant F105L in complex with myristic acid | | homo-2-mer | 19-178 | 99.35 | 2×MYR; 2×EDO; |
|
| Mutant L58F of recombinant bovine beta-lactoglobulin in complex with tetracaine | | homo-2-mer | 19-178 | 99.35 | 2×TE4; 2×SO4; |
|
| Mutant L39Y-L58F of recombinant bovine beta-lactoglobulin in complex with pramocaine | | homo-2-mer | 19-178 | 98.69 | 2×PX9; 2×SO4; |
|
| Mutant L58F of recombinant bovine beta-lactoglobulin in complex with pramocaine | | homo-2-mer | 19-178 | 99.35 | 2×PX9; 2×SO4; |
|
| Mutant L39Y-L58F of recombinant bovine beta-lactoglobulin in complex with endogenous fatty acid | | homo-2-mer | 19-178 | 98.69 | 2×DAO; 4×EDO; 2×SO4; 2×CL; |
|
| Engineered beta-lactoglobulin: variant M107L in complex with myristic acid | | homo-2-mer | 19-178 | 99.35 | 2×MYR; |
|
| Bovine beta-lactoglobulin crystallized in the presence of 2 mM zinc chloride | | homo-2-mer | 19-178 | 100 | 4×ZN; |
|
| Mutant L39K of recombinant beta-lactoglobulin in complex with endogenous ligand | | homo-2-mer | 19-178 | 99.33 | 2×DKA; 2×EDO; |
|
| Beta-lactoglobulin (low humidity) | | homo-2-mer | 17-176 | 98.75 | |
|
| Engineered beta-lactoglobulin: variant L39Y in complex with endogenous ligand | | homo-2-mer | 19-178 | 99.33 | 2×PLM; 6×EDO; |
|
| Mutant L39Y of recombinant bovine beta-lactoglobulin in complex with pramocaine | | homo-2-mer | 19-178 | 99.32 | 2×PX9; 2×SO4; 2×CL; |
|
| Engineered beta-lactoglobulin: variant I56F-L39A in complex with chlorpromazine (LG-FA-CLP) | | homo-2-mer | 19-178 | 98.72 | 2×Z80; |
|
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#2) | | homo-2-mer | 20-178 | 98.08 | 2×EDO; 3×DSM; 2×SO4; 2×CL; |
|
| Engineered beta-lactoglobulin: variant I56F-L39A-M107F in complex with chlorpromazine (LG-FAF-CLP) | | homo-2-mer | 20-178 | 98.06 | 2×Z80; 2×SO4; 2×GOL; 2×PO4; 2×CL; |
|
| Beta-lactoglobulin mutant FAF (I56F/L39A/M107F) in complex with desipramine (FAF-DSM) | | homo-2-mer | 20-178 | 98.1 | 4×DSM; 1×GOL; 1×CL; 1×EDO; 2×SO4; |
|
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#1) | | homo-2-mer | 20-178 | 98.08 | 1×SO4; 4×DSM; 1×CL; 2×EDO; |
|
| Beta-lactoglobulin mutant FAF (I56F/L39A/M107F), unliganded form | | homo-2-mer | 19-177 | 98.03 | 1×SO4; |
|
| Bovine beta-lactoglobulin crystallized in the presence of 20 mM zinc chloride | | homo-2-mer | 20-178 | 100 | 6×ZN; |
|
| Beta-lactoglobulin mutant FAW (I56F/L39A/M107W) in complex with desipramine (FAW-DSM#3) | | homo-2-mer | 20-177 | 98.1 | 2×DSM; 2×EDO; 4×SO4; 6×CL; |
|
| Mutant M107L of recombinant bovine beta-lactoglobulin in complex with tetracaine | | homo-2-mer | 21-178 | 99.35 | 2×TE4; |
|
| The Cys121Ser Mutant of Beta-Lactoglobulin | | homo-2-mer | 17-174 | 98.1 | |
|
| Engineered beta-lactoglobulin: variant M107L | | homo-2-mer | 19-176 | 99.31 | 2×GOL; 1×PO4; |
|
| Bovin Beta-lactoglobulin binding with zinc ions | | homo-2-mer | 22-178 | 100 | 6×ZN; |
|
| Recombinant bovine beta-lactoglobulin variant L1A/I2S (sBlgB#2) | | homo-2-mer | 17-173 | 98.66 | |
|
| The structure of bovine B-lactoglobulin A in crystals grown at very low ionic strength | | homo-2-mer | 21-176 | 98.72 | |
|
| HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA-LACTOGLOBULIN (ISOFORM A) | | homo-2-mer | 17-170 | 98.68 | |
|
| HIGH RESOLUTION CRYSTAL STRUCTURE OF THE BOVINE BETA-LACTOGLOBULIN (ISOFORMS A AND B) IN ORTHOROMBI… | | homo-2-mer | 17-168 | 100 | |
|
| Beta-lactoglobulin (native) | | homo-2-mer | 17-168 | 98.68 | |
|
| Engineered beta-lactoglobulin: variant F105L | | homo-2-mer | 17-168 | 97.76 | |
|
| Beta-lactoglobulin (reverse native) | | homo-2-mer | 17-168 | 98.68 | |
|
| Crystal structure of Gyuba, a patched chimera of b-lactglobulin | | homo-2-mer | 34-170 | 100 | |
|
| Bovine beta-lactoglobulin complex with capric acid | | monomer | 17-178 | 100 | 1×DKA; 1×GOL; 1×CL; |
|
| Bovine beta-lactoglobulin complex with caprylic acid | | monomer | 17-178 | 100 | 1×OCA; 1×CL; |
|
| Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo… | | monomer | 17-178 | 100 | 1×TDA; |
|
| Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo… | | monomer | 17-178 | 100 | 1×F15; 1×CL; |
|
| Bovine beta-lactoglobulin complex with pramocaine crystallized from sodium citrate (BLG-PRM1) | | monomer | 17-178 | 100.0 | 1×PX9; |
|
| Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 18 h of soaking | | monomer | 17-178 | 99.38 | 1×NH3; 1×PT; |
|
| Crystal structure of the Cisplatin beta-Lactoglobulin adduct formed after 72 h of soaking | | monomer | 17-178 | 100 | 1×NH3; 2×PT; |
|
| Bovine beta lactoglobulin unliganded form | | monomer | 17-178 | 100 | |
|
| STRUCTURAL AND FUNCTIONAL CONSEQUENCES OF POINT MUTATIONS OF VARIANTS A AND B OF BOVINE BETA-LACTOG… | | monomer | 17-178 | 100 | |
|
| Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo… | | monomer | 17-178 | 100 | 1×EW8; |
|
| Bovine beta-lactoglobulin complex with myristic acid at high pressure (0.55 GPa) | | monomer | 17-178 | 100 | 1×MYR; |
|
| STRUCTURAL BASIS OF THE TANFORD TRANSITION OF BOVINE BETA-LACTOGLOBULIN FROM CRYSTAL STRUCTURES AT … | | monomer | 17-178 | 98.77 | |
|
| Crystal structure of beta-lactoglobulin complexed with chloroquine | | monomer | 17-178 | 98.77 | 1×0TX; |
|
| Bovine beta-lactoglobulin complex with myristic acid, ambient pressure | | monomer | 17-178 | 100 | 1×MYR; |
|
| Unliganded form of bovine beta-lactoglobulin, ambient pressure | | monomer | 17-178 | 100 | 1×CL; |
|
| Bovine beta-lactoglobulin complex with dodecane at high pressure (0.43 GPa) | | monomer | 17-178 | 100 | 1×D12; 1×CL; |
|
| Energetic and structural effects of the Tanford transition on the ligand recognition of bovine Beta… | | monomer | 18-178 | 100.0 | 1×SDS; |
|
| Beta-lactoglobulin in complex with Cp*Rh(III)Cl N,N-di(pyridin-2-yl)dodecanamide | | monomer | 18-178 | 98.72 | 1×RHL; |
|
| Thermodynamic, Crystallographic and Computational Studies of Non Mammalian Fatty Acid Binding to Bo… | | monomer | 18-178 | 100 | 1×X90; |
|
| Crystal structure of a secondary vitamin D3 binding site of milk beta-lactoglobulin | | monomer | 18-178 | 100 | 2×VD3; |
|
| Bovine beta lactoglobulin crytsallized through ligandation of yttrium | | monomer | 18-178 | 100 | 2×YT3; 2×CL; |
|
| X.ray structure of the oxaliplatin/beta-lactoglobulin adduct | | monomer | 19-178 | 100 | 1×PT; |
|
| Engineered beta-lactoglobulin: variant L58F in complex with myristic acid | | monomer | 19-178 | 99.32 | 1×MYR; 1×SO4; |
|
| The structure of bovine beta-lactoglobulin in novel crystals grown at pH 3.8 | | monomer | 18-177 | 100 | 1×CA; |
|
| BOVINE BETA-LACTOGLOBULIN A | | monomer | 19-178 | 98.75 | |
|
| STRUCTURAL CHANGES ACCOMPANYING PH-INDUCED DISSOCIATION OF THE B-LACTOGLOBULIN DIMER | | monomer | 19-178 | 98.75 | |
|
| Bovine beta lactoglobulin crystallized through ligandation of yttrium cations | | monomer | 20-178 | 100 | 2×YT3; 2×CL; |
|
| Crystal structure of dha bind to bovine beta-lactoglobulin | | monomer | 20-178 | 100 | |
|
| BOVINE BETA-LACTOGLOBULIN, LATTICE X | | monomer | 21-176 | 99.36 | |
|